Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis - A prospective randomized study

International Journal of Colorectal Disease

Volumn 29, Issue 3, 2014, Pages 387-393

  Krokowicz, Lukasz ^a   Stojcev, Zoran ^b,c   Kaczmarek, Bartosz Filip ^d   Kociemba, Wojciech ^a   Kaczmarek, Elzbieta ^a   Walkowiak, Jaroslaw ^a   Krokowicz, Piotr ^a   Drews, Michal ^a   Banasiewicz, Tomasz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Regional Specialist Hospital   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d Holy Family Hospital   (Poland)

Author keywords

Diverticulitis; Diverticulosis; Prevention; Sodium butyrate

Indexed keywords

BUTYRIC ACID; DEBUTIR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BARIUM ENEMA; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIVERTICULITIS; DIVERTICULOSIS; FEMALE; FEVER; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROENCAPSULATION; MIDDLE AGED; PAIN; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME;

BUTYRIC ACID; CAPSULES; DIVERTICULITIS, COLONIC; DIVERTICULOSIS, COLONIC; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 84896048381     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-013-1807-5     Document Type: Article

References (35)

1. Parks TG (1975) Natural history of diverticular disease of the colon. Clin Gastroenterol 4:3-21
2. Floch MH, Bina I (2004) The natural history of diverticulitis: fact and theory. J Clin Gastroenterol 38:S2-S7 (Pubitemid 38544532)
3. Munson KD, Hensien MA, Jacob LN, Robinson AM, Liston WA (1996) Diverticulitis: a comprehensive follow-up. Dis Colon Rectum 39:318-324
4. World Medical Association (2008) WMA Declaration of Helsinki - ethical principles for medical research involving human subjects, Seoul, Korea
5. Mizuki A,Nagata H, Tatemichi M, Kaneda S, Tsukada N, Ishii H, Hibi T (2005) The out-patient management of patients with acute mild-to-moderate colonic diverticulitis. Aliment Pharmacol Ther 21:889-897 (Pubitemid 40477249)
6. Ambrosetti P, Jenny A, Becker C, Terrier TF, Morel P (2000) Acute left colonic diverticulitis - compared performance of computed tomography and water-soluble contrast enema: prospective evaluation of 420 patients. Dis Colon Rectum 43(10):1363-1367
7. Etzioni DA, Mack TM, Beart RW Jr, Kaiser AM (2009) Diverticulitis in the United States: 1998-2005: changing patterns of disease and treatment. Ann Surg 249:210-217
8. Krukowski ZH, Matheson NA (1984) Emergency surgery for diverticular disease complicated by generalized and faecal peritonitis: a review. Br J Surg 71:921-927 (Pubitemid 15218306)
9. Wong WD, Wexner SD, Lowry A, Vernava A III, Burnstein M (2000) Practice parameters for the treatment of sigmoid diverticulitis - supporting documentation. The Standards Task Force. The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 43:290-297
10. Parks TG (1969) Natural history of diverticular disease of the colon. A review of 521 cases. Br Med J 4:639-642
11. Peppas G, Bliziotis LA, Oikonomaki D, Falagas ME (2007) Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence. J Gastroenterol Hepatol 22:1360-1368 (Pubitemid 47274598)
12. Brodribb AJ (1977) Treatment of symptomatic diverticular disease with a high-fibre diet. Lancet 1:664-666
13. Ornstein MH, Little wood ER, Baird IM, Fowler J, North WR, Cox AG (1981) Are fibre supplements really necessary in diverticular disease of the colon? A controlled clinical trial. Br Med J (Clin Res Ed) 282: 1353-1356
14. Lupton JR, Turner ND (1999) Potential protective mechanisms of wheat bran fiber. Am J Med 106:24-27
15. Tan KY, Seow-Choen F (2007) Fiber and colorectal diseases: separating fact from fiction. World J Gastroenterol 13:4161-4167
16. Gronek P, Holdys J. (2013) Genes and physical fitness. Trends in Sport Sciences 20(1):16-29.
17. Tursi A, Brandimarte G, Daffinà R (2002) Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 34:510-515 (Pubitemid 34830693)
18. Colecchia A, Vestito A, Pasqui F, Mazzella G, Roda E, Pistoia F (2007) Efficacy of long term cyclic administration of the poorly absorbed antibiotic rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 13:264-269 (Pubitemid 46231330)
19. Fric P, Zavoral M (2003) The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 15:313-315 (Pubitemid 36337852)
20. Giaccari S, Tronci S, Falconieri M, Ferrieri A (1993) Long-term treatment with rifaximin and lactobacilli in post-diverticulitic stenoses of the colon. Riv Eur Sci Med Farmacol 15:29-34 (Pubitemid 24082637)
21. Lamiki P, Tsuchiya J, Pathak S, Okura R, Solimene U, Jain S (2010) Probiotics in diverticular disease of the colon: an open label study. J Gastrointestin Liver Dis 19:31-36
22. Banasiewicz T, Krokowicz L, Stojcev Z, Kaczmarek BF, Kaczmarek E, Maik J, Marciniak R, Krokowicz P, Walkowiak J, Drews M (2013) Microencapsulated sodiumbutyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome. Colorectal Dis 15: 204-209
23. Cordel S, Dupas B, Douillard JY, Meflah K (1998) Interleukin-2/sodium butyrate treatment cures rats bearing liver tumors after acquired 5-fluorouracil resistance. Int J Cancer 78:735-739 (Pubitemid 28530397)
24. Hall JF, Roberts PL, Ricciardi R (2011) Long-term follow-up after an initial episode of diverticulitis: what are the predictors of recurrence? Dis Colon Rectum 54:283-288
25. Vernia P, Annese V, Bresci G, d'Albasio G, D'Incà R, Giaccari S (2003) Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Investig 33:244-248 (Pubitemid 36411543)
26. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ (2008) Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27:104-119 (Pubitemid 350256609)
27. Topping DL, Clifton PM (2001) Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81:1031-1064 (Pubitemid 32611227)
28. Canani RB, Terrin G, Cirillo P, Castaldo G, Salvatore F, Cardillo G, Coruzzo A, Troncone R (2004) Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology 127:630-634 (Pubitemid 39091910)
29. Schmitt MG Jr, Soergel KH, Wood CM (1976) Absorption of short chain fatty acids from the human jejunum. Gastroenterology 70: 211-215
30. Clemens CH, Samsom M, Roelofs J, van Berge Henegouwen GP, Smout AJ (2004) Colorectal visceral perception in diverticular disease. Gut 53:717-722 (Pubitemid 38561451)
31. Petruzziello L, Iacopini F, Bulajic M, Shah S, Costamanga G (2006) Review article: uncomplicated diverticular disease of the colon. Aliment Pharmacol Ther 23:1379-1391
32. Roda A, Simoni P, Magliulo M, Nanni P, Baraldini M, Roda G, Roda E (2007) A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon. World J Gastroenterol 13:1079-1084 (Pubitemid 46511010)
33. Zullo A, Hassan C, Maconi G, Manes G, Tammaro G, De Francesco V, Annibale B, Ficano L,Buri L,Gatto G, Lorenzetti R, Campo SM, Ierardi E, Pace F, Morini S (2010) Cyclic antibiotic therapy for diverticular disease: a critical reappraisal. J Gastrointestin Liver Dis 19:295-302
34. Bijkerk CJ, de Wit NJ, Muris JW, Jones RH, Knottnerus JA, Hoes AW (2003) Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol 98:122-127 (Pubitemid 36135180)
35. IIrvine EJ,Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ et al (2006) Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 130:1538-1551